Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to -$69.5 million.

  • P3 Health Partners' Net Income towards Common Stockholders rose 3246.38% to -$69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$286.5 million, marking a year-over-year decrease of 1445.37%. This contributed to the annual value of -$310.4 million for FY2024, which is 6648.86% down from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Net Income towards Common Stockholders is -$69.5 million, which was up 3246.38% from -$43.7 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Net Income towards Common Stockholders peaked at -$10.6 million during Q1 2022, and registered a low of -$903.1 million during Q2 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$49.6 million (2024), whereas its average is -$121.7 million.
  • Per our database at Business Quant, P3 Health Partners' Net Income towards Common Stockholders crashed by 296507.41% in 2022 and then soared by 9694.59% in 2023.
  • Over the past 5 years, P3 Health Partners' Net Income towards Common Stockholders (Quarter) stood at -$60.2 million in 2021, then plummeted by 783.82% to -$532.3 million in 2022, then skyrocketed by 87.02% to -$69.1 million in 2023, then plummeted by 86.88% to -$129.1 million in 2024, then surged by 46.22% to -$69.5 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$69.5 million for Q3 2025, versus -$43.7 million for Q2 2025 and -$44.2 million for Q1 2025.